Results 81 to 90 of about 56,212 (261)

Hemolytic anemia

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2014
Summary: Hemolytic anemia is a collection of diseases resulting from an exaggeration of the lysis of red blood cells. Hemolysis can be caused by extravacular aggression by drugs or other toxic or by antibodies againt red blood cell.
JAMILA ELHOUDZI
doaj  

Lupus Anticoagulant Positivity as a Risk Marker for Hemolytic Anemia in Patients with APS

open access: yesMedicina
Background and Objectives: Thrombocytopenia and hemolytic anemia are common but non-criteria manifestations of antiphospholipid syndrome (APS). However, their relationship with specific immunological profiles remains poorly characterized.
Ji-Hyoun Kang
doaj   +1 more source

Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report

open access: yesClinical Case Reports, 2017
Key Clinical Message We report a rare case of severe autoimmune hemolytic anemia triggered by pegylated interferon during combination therapy for chronic HCV.
Shasha Wang   +3 more
doaj   +1 more source

The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Red blood cell (RBC) alloimmunization remains a relevant cause of hemolytic disease of the fetus and newborn (HDFN). Although RhD immunization has significantly decreased since the implementation of systematic prophylaxis, it is still the main cause of alloimmunization in pregnancy.
Mar Bennasar, Antoni Borrell
wiley   +1 more source

Biological Specificities of Fetal Anemia Induced by Parvovirus B19 Infection

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Objective To describe the biological fetal parameters in cases of severe anemia induced by parvovirus B19 (B19V) infection. Method A retrospective single center study was conducted including cases of fetal anemia due to B19V receiving in utero transfusion (IUT) from January 2011 to May 2024.
Anaïs Dugas   +9 more
wiley   +1 more source

Gilbert syndrome in patients with inherited hemolytic anemia modifies the clinical phenotype

open access: yesPediatric Hematology Oncology Journal
Gilbert syndrome is a benign condition due to UGT1A1 mutations frequently resulting in mild, indirect hyperbilirubinemia. Inherited hemolytic anemias often present with hyperbilirubinemia and hepatosplenomegaly.
Anika Agrawal, Jagdish Chandra
doaj   +1 more source

Preclinical Efficacy and Safety Evaluation of a Novel Controlled‐Expansion ePTFE‐Covered TIPS Stent in a Swine Model

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This preclinical study evaluated a novel controlled‐expansion expanded polytetrafluoroethylene (ePTFE)‐covered transjugular intrahepatic portosystemic shunt (TIPS) stent in 11 swine, demonstrating 100% technical success, excellent deployability, and durable 6‐month angiographic patency without thrombosis, migration, fracture, or device‐related toxicity.
Yi Xiang   +15 more
wiley   +1 more source

Evaluation of the collection and storage of packed red blood cells in ferrets

open access: yesVeterinary Record, EarlyView.
Abstract Background Blood transfusion is lifesaving in anaemic ferrets, but species‐specific blood‐banking systems are lacking, and optimal storage conditions for packed red blood cells (pRBCs) have not been established. Therefore, this study aimed to assess the bacteriological, biochemical and haematological stability of pRBC stored in citrate ...
Audrey Alsac   +3 more
wiley   +1 more source

Deficiency of high‐molecular‐weight von Willebrand factor mitigates thrombo‐complement injury in an LPS‐induced TMA‐like mouse model

open access: yesVIEW, EarlyView.
Reduction of high‐molecular‐weight von Willebrand factor disrupts the platelet–complement amplification loop, attenuating microvascular thrombosis, complement deposition, endothelial injury, and organ damage in complement‐mediated thrombotic microangiopathy.
Yang Li   +17 more
wiley   +1 more source

Nomenclature on Immune‐Mediated Drug Reactions: An EAACI Position Paper

open access: yesAllergy, EarlyView.
ABSTRACT Over the past several decades, there have been significant advances in our understanding of both immunological and pharmacological mechanisms of adverse drug reactions (ADRs). Immune‐mediated drug reactions (IMDRs) represent a small proportion of ADRs and are caused by a pathological activation of the immune system or inflammatory pathways ...
Maria J. Torres   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy